Clinical Trial Update: ImmunoBreast - A Phase Ib Study [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for ImmunoBreast in breast cancer, including triple-negative and metastatic disease, with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• ImmunoBreast

Snippet

Sponsor: Henrik Ditzel | Conditions: Triple Negative Breast Cancer, Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN